These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 12651907)

  • 21. Characterization of expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in prostate cancer cell lines.
    Daja MM; Niu X; Zhao Z; Brown JM; Russell PJ
    Prostate Cancer Prostatic Dis; 2003; 6(1):15-26. PubMed ID: 12664060
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cell density-dependent regulation of matrix metalloproteinase and TIMP expression in differently tumorigenic breast cancer cell lines.
    Bachmeier BE; Albini A; Vené R; Benelli R; Noonan D; Weigert C; Weiler C; Lichtinghagen R; Jochum M; Nerlich AG
    Exp Cell Res; 2005 Apr; 305(1):83-98. PubMed ID: 15777790
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Expression and clinical significance of MMP-2, MMP-9,TIMP-1, and TIMP-2 in breast carcinoma].
    Fan SQ; Wei QY; Li MR; Zhang LQ; Liang QC
    Ai Zheng; 2003 Sep; 22(9):968-73. PubMed ID: 12969531
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association of a high activity of matrix metalloproteinase-9 to low levels of tissue inhibitors of metalloproteinase-1 and -3 in human hepatitis B-viral hepatoma cells.
    Kim JR; Kim CH
    Int J Biochem Cell Biol; 2004 Nov; 36(11):2293-306. PubMed ID: 15313474
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effect of epidermal growth factor on matrix metalloproteinases and tissue inhibitors of metalloproteinase gene expression in cultured human gingival fibroblasts.
    Cury PR; de Araújo VC; Canavez F; Furuse C; Leite KR; de Araújo NS
    Arch Oral Biol; 2007 Jun; 52(6):585-90. PubMed ID: 17181997
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tissue inhibitor of metalloproteinase 1 is an independent predictor of prognosis in patients with nonsmall cell lung carcinoma who undergo resection with curative intent.
    Gouyer V; Conti M; Devos P; Zerimech F; Copin MC; Créme E; Wurtz A; Porte H; Huet G
    Cancer; 2005 Apr; 103(8):1676-84. PubMed ID: 15754326
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differential expression of matrix metalloproteinases and tissue inhibitors and extracellular matrix remodeling in aortic regurgitant hearts.
    Truter SL; Catanzaro DF; Supino PG; Gupta A; Carter J; Herrold EM; Dumlao TF; Borer JS
    Cardiology; 2009; 113(3):161-8. PubMed ID: 19129699
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The value and correlation between PRL-3 expression and matrix metalloproteinase activity and expression in human gliomas.
    Kong L; Li Q; Wang L; Liu Z; Sun T
    Neuropathology; 2007 Dec; 27(6):516-21. PubMed ID: 18021371
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Equine laminitis: membrane type matrix metalloproteinase-1 (MMP-14) is involved in acute phase onset.
    Kyaw-Tanner MT; Wattle O; van Eps AW; Pollitt CC
    Equine Vet J; 2008 Jul; 40(5):482-7. PubMed ID: 18178538
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Analysis of expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in human ciliary body after latanoprost.
    Oh DJ; Martin JL; Williams AJ; Peck RE; Pokorny C; Russell P; Birk DE; Rhee DJ
    Invest Ophthalmol Vis Sci; 2006 Mar; 47(3):953-63. PubMed ID: 16505029
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Regulation of the extracellular matrix remodeling by lutein in dermal fibroblasts, melanoma cells, and ultraviolet radiation exposed fibroblasts.
    Philips N; Keller T; Hendrix C; Hamilton S; Arena R; Tuason M; Gonzalez S
    Arch Dermatol Res; 2007 Oct; 299(8):373-9. PubMed ID: 17710425
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression of matrix metalloproteinases in the microenvironment of spontaneous and experimental melanoma metastases reflects the requirements for tumor formation.
    Hofmann UB; Eggert AA; Blass K; Bröcker EB; Becker JC
    Cancer Res; 2003 Dec; 63(23):8221-5. PubMed ID: 14678978
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition of cancer cell invasion by cannabinoids via increased expression of tissue inhibitor of matrix metalloproteinases-1.
    Ramer R; Hinz B
    J Natl Cancer Inst; 2008 Jan; 100(1):59-69. PubMed ID: 18159069
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of basic fibroblast factor (bFGF) on MMP-2, TIMP-2, and type-I collagen levels in human lung carcinoma fibroblasts.
    Nakoman C; Resmi H; Ay O; Acikel U; Atabey N; Güner G
    Biochimie; 2005; 87(3-4):343-51. PubMed ID: 15781321
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Relationships between matrix metalloproteinases and tissue inhibitor of metalloproteinases in the wall of abdominal aortic aneurysms.
    Nishimura K; Ikebuchi M; Kanaoka Y; Ohgi S; Ueta E; Nanba E; Ito H
    Int Angiol; 2003 Sep; 22(3):229-38. PubMed ID: 14612849
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Expression of matrix metalloproteinases and their inhibitors in fetal skin and their biological significance].
    Li WJ; Chen W; Fu XB; Zhu RZ
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2006 May; 18(5):303-6. PubMed ID: 16701000
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression of matrix metalloproteinases and their inhibitors in medulloblastomas and their prognostic relevance.
    Ozen O; Krebs B; Hemmerlein B; Pekrun A; Kretzschmar H; Herms J
    Clin Cancer Res; 2004 Jul; 10(14):4746-53. PubMed ID: 15269148
    [TBL] [Abstract][Full Text] [Related]  

  • 38. mRNA expression profile of matrix metalloproteinases and their tissue inhibitors in malignant and non-malignant prostatic tissue.
    Lichtinghagen R; Musholt PB; Stephan C; Lein M; Kristiansen G; Hauptmann S; Rudolph B; Schnorr D; Loening SA; Jung K
    Anticancer Res; 2003; 23(3B):2617-24. PubMed ID: 12894549
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression of matrix metalloproteinases and tissue inhibitors of metalloproteinase in uterine endometrial carcinoma and a correlation between expression of matrix metalloproteinase-7 and prognosis.
    Misugi F; Sumi T; Okamoto E; Nobeyama H; Hattori K; Yoshida H; Matsumoto Y; Yasui T; Honda K; Ishiko O
    Int J Mol Med; 2005 Oct; 16(4):541-6. PubMed ID: 16142384
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increased acinar damage of salivary glands of patients with Sjögren's syndrome is paralleled by simultaneous imbalance of matrix metalloproteinase 3/tissue inhibitor of metalloproteinases 1 and matrix metalloproteinase 9/tissue inhibitor of metalloproteinases 1 ratios.
    Pérez P; Kwon YJ; Alliende C; Leyton L; Aguilera S; Molina C; Labra C; Julio M; Leyton C; González MJ
    Arthritis Rheum; 2005 Sep; 52(9):2751-60. PubMed ID: 16142742
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.